Dinarello, 2019 - Google Patents
The IL-1 family of cytokines and receptors in rheumatic diseasesDinarello, 2019
- Document ID
- 4313319445457970599
- Author
- Dinarello C
- Publication year
- Publication venue
- Nature Reviews Rheumatology
External Links
Snippet
More than any other cytokine family, the 11 members of the IL-1 family are associated with innate immune responses, which occur in acute inflammation and chronic inflammatory conditions such as rheumatic diseases. In many rheumatic diseases, the severity of the …
- 102000026225 IL-1 family 0 title abstract description 52
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dinarello | The IL-1 family of cytokines and receptors in rheumatic diseases | |
Bertheloot et al. | HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins | |
Holzinger et al. | Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases | |
Ji et al. | Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis | |
Moltó et al. | Anti-IL-1 molecules: new comers and new indications | |
US10940126B2 (en) | Inhibition of IL-8 in the treatment of pain and/or bone loss | |
US20090142806A1 (en) | Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor | |
EP1743648A1 (en) | Method for treating inflammation | |
Harel et al. | Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases | |
AU2005277236A1 (en) | Methods and compositions for treating allergic inflammation | |
Hernandez‐Santana et al. | Current perspectives on the interleukin‐1 family as targets for inflammatory disease | |
Wang et al. | Interleukin-18 and IL-18BP in inflammatory dermatological diseases | |
CA2754945C (en) | Peptides and sirna for modulating inflammation | |
Yang et al. | Interleukin-9 aggravates isoproterenol-induced heart failure by activating signal transducer and activator of transcription 3 signalling | |
US20200255825A1 (en) | Biological materials and therapeutic uses thereof | |
Lavric et al. | Alarmins firing arthritis: helpful diagnostic tools and promising therapeutic targets | |
Galozzi et al. | Development and role in therapy of canakinumab in adult-onset Still’s disease | |
Yuan | IL-33 in autoimmunity; possible therapeutic target | |
Ouyang et al. | Potential mechanistic roles of Interleukin-33 in rheumatoid arthritis | |
EP3316886B1 (en) | Methods and compounds for the alleviation and/or prevention of pain | |
TW202106712A (en) | Methods of diagnosis and treatment of rheumatoid arthritis | |
WO2013070563A1 (en) | Treatment of autoimmune and inflammatory disorders by inhibition of blimp-1 | |
Crofford | The role of COX-2 in rheumatoid arthritis synovial tissues | |
Dumont | The interleukin-1 families of cytokines and receptors: therapeutic potential for immunomodulation and the treatment of inflammatory disorders | |
Kevin et al. | IL-23 in arthritic and inflammatory pain development in mice |